Author |
Title |
JournalName |
Year D |
Click on Column Headers to Re-Sort The Current List |
Beck J, Morgan PA |
Designer drug confusion: a focus on MDMA |
J Drug Educ |
1986 |
Buffum J, Moser C |
MDMA and human sexual function |
J Psychoactive Drugs |
1986 |
Climko RP, Roehrich H, Sw... |
Ecstacy: a review of MDMA and MDA |
Int J Psychiatry Med |
1986 |
Downing J |
The psychological and physiological effects of MDMA on normal voluntee... |
J Psychoactive Drugs |
1986 |
Lyon RA, Glennon RA, Tite... |
3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions... |
Psychopharmacology (... |
1986 |
Nichols DE |
Differences between the mechanism of action of MDMA, MBDB, and the cla... |
J Psychoactive Drugs |
1986 |
Shulgin AT |
The background and chemistry of MDMA |
J Psychoactive Drugs |
1986 |
Brown C, Osterloh J |
Multiple severe complications from recreational ingestion of MDMA ('Ec... |
JAMA |
1987 |
Dowling GP, McDonough ET ... |
'Eve' and 'Ecstasy'. A report of five deaths associated with the use o... |
JAMA |
1987 |
Glennon RA, Little PJ, Ro... |
The effect of MDMA ('Ecstasy') and its optical isomers on schedule-con... |
Pharmacol Biochem Be... |
1987 |
Kulmala HK, Boja JW, Sche... |
Behavioral suppression following 3,4-methylenenedioxymethamphetamine |
Life Sci |
1987 |
Mokler DJ, Robinson SE, R... |
(+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reduc... |
Eur J Pharmacol |
1987 |
Peroutka SJ |
Incidence of recreational use of 3,4-methylenedimethoxymethamphetamine... |
N Engl J Med |
1987 |
Ricaurte GA, Finnegan KF,... |
3,4-Methylenedioxyethylamphetamine (MDE), a novel analogue of MDMA, pr... |
Eur J Pharmacol |
1987 |
Rosecrans JA, Glennon RA |
The effect of MDA and MDMA ('Ecstasy') isomers in combination with pir... |
Pharmacol Biochem Be... |
1987 |
Steele TD, Nichols DE, Yi... |
Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and... |
Biochem Pharmacol |
1987 |
Stone DM, Hanson GR, Gibb... |
Differences in the central serotonergic effects of methylenedioxymetha... |
Neuropharmacology |
1987 |
Finnegan KT, Ricaurte GA,... |
Orally administered MDMA causes a long-term depletion of serotonin in ... |
Brain Res |
1988 |
Battaglia G, Yeh SY, de S... |
MDMA-induced neurotoxicity: parameters of degeneration and recovery of... |
Pharmacol Biochem Be... |
1988 |
Glennon RA, Yousif M, Pat... |
Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MD... |
Pharmacol Biochem Be... |
1988 |
Mamounas LA, Molliver ME |
Evidence for dual serotonergic projections to neocortex: axons from th... |
Exp Neurol |
1988 |
Oberlender R, Nichols DE |
Drug discrimination studies with MDMA and amphetamine |
Psychopharmacology (... |
1988 |
Peroutka SJ, Newman H, Ha... |
Subjective effects of 3,4-methylenedioxymethamphetamine in recreationa... |
Neuropsychopharmacol... |
1988 |
Ruangyuttikarn W, Moody D... |
Comparison of three commercial amphetamine immunoassays for detection ... |
J Anal Toxicol |
1988 |
Schechter MD |
Advantages and disadvantages of a rapid method to train drug discrimin... |
Pharmacol Biochem Be... |
1988 |
Slikker W Jr, Ali SF, Sca... |
Neurochemical and neurohistological alterations in the rat and monkey ... |
Toxicol Appl Pharmac... |
1988 |
Stone DM, Johnson M, Hans... |
Role of endogenous dopamine in the central serotonergic deficits induc... |
J Pharmacol Exp Ther |
1988 |
Cozzi NV, Sievert MK, Shu... |
Methcathinone and 2-methylamino-1-(3,4-methylenedioxyphenyl)propan-1-o... |
Soc. Neurosci. Abs |
1988 |
Wilkerson G, London ED |
Effects of methylenedioxymethamphetamine on local cerebral glucose uti... |
Neuropharmacology |
1989 |
Schechter MD |
Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetami... |
Pharmacol Biochem Be... |
1989 |
Crisp T, Stafinsky JL, Bo... |
The antinociceptive effects of 3,4-methylenedioxymethamphetamine (MDMA... |
Pharmacol Biochem Be... |
1989 |
De Souza EB, Battaglia G |
Effects of MDMA and MDA on brain serotonin neurons: evidence from neur... |
NIDA Res Monogr |
1989 |
Dimpfel W, Spuler M, Nich... |
Hallucinogenic and stimulatory amphetamine derivatives: fingerprinting... |
Psychopharmacology (... |
1989 |
Fitzgerald RL, Blanke RV,... |
Stereochemistry of the metabolism of MDMA to MDA |
Life Sci |
1989 |
Glennon RA, Misenheimer B... |
Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopr... |
Pharmacol Biochem Be... |
1989 |
Gold LH, Hubner CB, Koob ... |
A role for the mesolimbic dopamine system in the psychostimulant actio... |
Psychopharmacology (... |
1989 |
Hiramatsu M, Nabeshima T,... |
The effect of optical isomers of 3,4-methylenedioxymethamphetamine (MD... |
Pharmacol Biochem Be... |
1989 |
Insel TR, Battaglia G, Jo... |
3,4-Methylenedioxymethamphetamine ('ecstasy') selectively destroys bra... |
J Pharmacol Exp Ther |
1989 |
Johnson MP, Nichols DE |
Neurotoxic effects of the alpha-ethyl homologue of MDMA following suba... |
Pharmacol Biochem Be... |
1989 |
Matthews RT, Champney TH,... |
Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopam... |
Pharmacol Biochem Be... |
1989 |
Peroutka SJ |
'Ecstasy': a human neurotoxin? |
Arch Gen Psychiatry |
1989 |
Ricaurte GA |
Studies of MDMA-induced neurotoxicity in nonhuman primates: a basis fo... |
NIDA Res Monogr |
1989 |
Sadzot B, Baraban JM, Gle... |
Hallucinogenic drug interactions at human brain 5-HT2 receptors: impli... |
Psychopharmacology (... |
1989 |
Schmidt CJ |
Acute and long-term neurochemical effects of methylenedioxymethampheta... |
NIDA Res Monogr |
1989 |
Slikker W Jr, Holson RR, ... |
Behavioral and neurochemical effects of orally administered MDMA in th... |
Neurotoxicology |
1989 |
Spanos LJ, Yamamoto BK |
Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MD... |
Pharmacol Biochem Be... |
1989 |
Sprouse JS, Bradberry CW,... |
MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal... |
Eur J Pharmacol |
1989 |
Glennon RA, Misenheimer B... |
Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopr... |
Pharmacol Biochem Be... |
1989 |
Bilsky EJ, Hui YZ, Hubbel... |
Methylenedioxymethamphetamine's capacity to establish place preference... |
Pharmacol Biochem Be... |
1990 |
Cho AK, Hiramatsu M, Dist... |
Stereochemical differences in the metabolism of 3,4-methylenedioxymeth... |
Drug Metab Dispos |
1990 |
Finnegan KT, Skratt JJ, I... |
The N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prev... |
Neurosci Lett |
1990 |
Fitzgerald RL, Blanke RV,... |
Stereoselective pharmacokinetics of 3,4-methylenedioxymethamphetamine ... |
Chirality |
1990 |
Hashimoto K, Goromaru T |
Reduction of in vivo binding of [3H]paroxetine in mouse brain by 3,4-m... |
Neuropharmacology |
1990 |
McKenna DJ, Peroutka SJ |
Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine ... |
J Neurochem |
1990 |
Molliver ME, Berger UV, M... |
Neurotoxicity of MDMA and related compounds: anatomic studies |
Ann N Y Acad Sci |
1990 |
Ricaurte GA, Finnegan KT,... |
Aminergic metabolites in cerebrospinal fluid of humans previously expo... |
Ann N Y Acad Sci |
1990 |
Schmidt CJ, Black CK, Tay... |
Antagonism of the neurotoxicity due to a single administration of meth... |
Eur J Pharmacol |
1990 |
Zacny JP, Virus RM, Woolv... |
Tolerance and cross-tolerance to 3,4-methylenedioxymethamphetamine (MD... |
Pharmacol Biochem Be... |
1990 |
Ali SF, Chang LW, Slikker... |
Biogenic amines as biomarkers for neurotoxicity |
Biomed Environ Sci |
1991 |
Bilsky EJ, Hubbell CL, De... |
MDMA produces a conditioned place preference and elicits ejaculation i... |
Pharmacol Biochem Be... |
1991 |
Dornan WA, Katz JL, Ricau... |
The effects of repeated administration of MDMA on the expression of se... |
Pharmacol Biochem Be... |
1991 |
Dragunow M, Logan B, Lave... |
3,4-Methylenedioxymethamphetamine induces Fos-like proteins in rat bas... |
Eur J Pharmacol |
1991 |
Gan BK, Baugh D, Liu RH, ... |
Simultaneous analysis of amphetamine, methamphetamine, and 3, 4-methyl... |
J Forensic Sci |
1991 |
Gordon CJ, Watkinson WP, ... |
Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregula... |
Pharmacol Biochem Be... |
1991 |
Kumagai Y, Wickham KA, Sc... |
Metabolism of methylenedioxyphenyl compounds by rabbit liver preparati... |
Biochem Pharmacol |
1991 |
McCann UD, Ricaurte GA |
Lasting neuropsychiatric sequelae of (+-)methylenedioxymethamphetamine... |
J Clin Psychopharmac... |
1991 |
McGuire P, Fahy T |
Chronic paranoid psychosis after misuse of MDMA ('ecstasy') |
BMJ |
1991 |
Nash JF, Nichols DE |
Microdialysis studies on 3,4-methylenedioxyamphetamine and structurall... |
Eur J Pharmacol |
1991 |
Nichols DE, Johnson MP, O... |
5-Iodo-2-aminoindan, a nonneurotoxic analogue of p-iodoamphetamine |
Pharmacol Biochem Be... |
1991 |
Paulus MP, Geyer MA |
A temporal and spatial scaling hypothesis for the behavioral effects o... |
Psychopharmacology (... |
1991 |
Schechter MD |
Effect of MDMA neurotoxicity upon its conditioned place preference and... |
Pharmacol Biochem Be... |
1991 |
Schechter MD |
Effect of serotonin depletion by p-chlorophenylalanine upon discrimina... |
Gen Pharmacol |
1991 |
Schifano F |
Chronic atypical psychosis associated with MDMA ('ecstasy') abuse |
Lancet |
1991 |
Sharkey J, McBean DE, Kel... |
Alterations in hippocampal function following repeated exposure to the... |
Psychopharmacology (... |
1991 |
Yeh SY, Hsu FL |
The neurochemical and stimulatory effects of putative metabolites of 3... |
Pharmacol Biochem Be... |
1991 |
Henry JA, Jeffreys KJ, Da... |
Toxicity and deaths from 3,4-methylenedioxymethamphetamine ('ecstasy') |
Lancet |
1992 |
Abbott A, Concar D |
A trip into the unknown |
New Scientist |
1992 |
Berger UV, Gu XF, Azmitia... |
The substituted amphetamines 3,4-methylenedioxymethamphetamine, metham... |
Eur J Pharmacol |
1992 |
Callaway CW, Geyer MA |
Tolerance and cross-tolerance to the activating effects of 3,4-methyle... |
J Pharmacol Exp Ther |
1992 |
Callaway CW, Rempel N, Pe... |
Serotonin 5-HT1-like receptors mediate hyperactivity in rats induced b... |
Neuropsychopharmacol... |
1992 |
Glennon RA, Higgs R |
Investigation of MDMA-related agents in rats trained to discriminate M... |
Pharmacol Biochem Be... |
1992 |
Henry JA |
Ecstasy and the dance of death |
BMJ |
1992 |
Johnson M, Mitros K, Ston... |
Effect of flunarizine and nimodipine on the decrease in tryptophan hyd... |
J Pharmacol Exp Ther |
1992 |
Kumagai Y, Schmitz DA, Ch... |
Aromatic hydroxylation of methylenedioxybenzene (MDB) and methylenedio... |
Xenobiotica |
1992 |
Nash JF, Yamamoto BK |
Methamphetamine neurotoxicity and striatal glutamate release: comparis... |
Brain Res |
1992 |
Scheffel U, Lever JR, Sta... |
Repeated administration of MDMA causes transient down-regulation of se... |
Neuropharmacology |
1992 |
Steele TD, Katz JL, Ricau... |
Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-amin... |
Brain Res |
1992 |
Thurman EM, Pedersen MJ, ... |
Distinguishing sympathomimetic amines from amphetamine and methampheta... |
J Anal Toxicol |
1992 |
Heilig, Steve |
MDMA Update: The Science and Politics of Ecstasy |
Newsletter of the Ca... |
1993 |
Cody JT, Schwarzhoff R |
Fluorescence polarization immunoassay detection of amphetamine, metham... |
J Anal Toxicol |
1993 |
Allen RP, McCann UD, Rica... |
Persistent effects of (+/- )3,4-methylenedioxymethamphetamine (MDMA, '... |
Sleep |
1993 |
Brodkin J, Malyala A, Nas... |
Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetami... |
Pharmacol Biochem Be... |
1993 |
Finnegan KT, Calder L, Cl... |
Effects of L-type calcium channel antagonists on the serotonin-depleti... |
Brain Res |
1993 |
Fitzgerald JL, Reid JJ |
Interactions of methylenedioxymethamphetamine with monoamine transmitt... |
Naunyn Schmiedebergs... |
1993 |
Hashimoto K, Maeda H, Hir... |
Drug effects on distribution of [3H]3,4-methylenedioxymethamphetamine ... |
Eur J Pharmacol |
1993 |
Huang X, Nichols DE |
5-HT2 receptor-mediated potentiation of dopamine synthesis and central... |
Eur J Pharmacol |
1993 |
Johnson M, Bush LG, Hanso... |
Effects of ritanserin on the 3,4-methylenedioxymethamphetamine-induced... |
Biochem Pharmacol |
1993 |
Ricaurte GA, Markowska AL... |
3,4-Methylenedioxymethamphetamine, serotonin and memory [published err... |
J Pharmacol Exp Ther |
1993 |
Scanzello CR, Hatzidimitr... |
Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine ... |
J Pharmacol Exp Ther |
1993 |
Tirzite D, Tirzitis G, Vi... |
Effects of ritanserin on the 3,4-methylenedioxymethamphetamine-induced... |
Biochem Pharmacol |
1993 |